Диссертация (1140918), страница 22
Текст из файла (страница 22)
J. Physiol. - 1999. - V27, № 1 - P. 551-560.131150. Barnett A.H. Insulin-sensitizing agents -thiazolidinediones (glitazones) / A.H.Barnett A.H. // Curr Med Res Opin - 2002. - №18. - P. 31-91.151. Batsis J. A., Nieto-Martinez R. E. Metabolic syndrome: from globalepidemiology to individualized medicine // Clin. Pharmacol. Ther. 2007. - Vol. 82.
№ 5. - P. 509-524.152. Boden G. Free acids in obesity and type 2 diabetes: defining their role in thedevelopment of insulin resistance and b-cell dysfunction / G. Boden, G. Shulman //Eur. J. Clin. Invest. - 2002. - V.32, №3. - P. 14-23.153. Caro J.F. Obesity / J.F. Caro. // McGraw-Hill Yearbook of Science andTechnology. - 2000. - V. 76. - P.
139-141.154. Castelli W. Epidemioligy of triglycerides: view from Framingbam // Am JCardiol. - 1992. - № 70. - P. 34-94.155. Centonze V., Polito B.M., Bassi A. Altération de la hépatite chronique C.Intérêt de l'approche psychosomatique. // La presse thermale et climatique. 1997. vol. 134, N2.-P.71-75.156. Cuspidi C.
Prevalence and correlates of left atrial enlargement in essentialhypertension: role of ventricular geometry and the metabolic syndrome: theEvaluation of Target Organ Damage in Hypertension study / C. Cuspidi [et al.] // J.Hypertens. - 2005. - V.23. - P. 875-882.157. Dagenais G.R., Yi Q., Mann J., et al. Prognostic Impact of body weight andabdominal obesity in women and men with cardiovascular disease // Am. Heart J. 2005.
Vol. 149. - P. 54-60.158. Davis H., De-Nour A.K., Shouval D., Melmed R.N. Psychological distress inpatients with chronic, nonalcoholic, uncomplicated liver diseases // J. Psychosom.Res. - 1998. - Vol. 44, № 5. - P. 547-554.159. DeFronzo R.A. Insulin resistance, a multifaceted syndrome responsible forNIDDM, obesity, hypertension, dislipidemia and atherosclerotic cardiovasculardisease / R.A. DeFronzo, E. Ferrannini. // Diabetes Care. - 1991. - V.14, №3. - P.173-194.132160.
Dekker J. M., Rhodes Т., Nijpels G. Metabolic syndrome and 10-yearcardiovascular disease risk in the Hoom Study. Circulation. 2005. - № 112. - P. 66673.161. Ford E.S. Prevalence of the metabolic syndrome defined by the InternationalDiabetes Federation among adults in the U.S., Diabetes Care.2005 Nov;28(11):27459.162. Freeman, J. A. Does adding MS-specific items to a generic measure (the SF36) improve measurement? / J. A. Freeman, J. C.
Hobart [et al.] // Neurol. – 2001. –57(1). – P. 68–74.163. Goh-J; Coughlan-B; Quinn-J; O'Keane-JC; Crowe-J Fatigue does not correlatewith the degree of hepatitis or the presence of autoimmune disorders in chronichepatitis C infection. Eur. J. Gastroenterol-Hepatol. 1999 Aug.- Vol.11.- P. 833-838.164. Gotze P. Psychosomatic aspects in the intensive care unit after open Heartsurgery // Psychiatria Fennica. - 1981. - Suppl. 1. - P. 33-45.165.
Grundy S.M. Diagnosis and Management of the Metabolic Syndrome. AnAmerican Heart Association/National Heart, Lung, and Blood Institute ScientificStatement / S.M. Grundy [et al.] // Circulation. - 2005. - V. 12. - P. 189-202.166. Grundy S.M., Brewer H.B., Cleeman H.I., SmithS.C., Lenfant C. Definition ofmetabolicsyndrome:ReportoftheNationalHeart,Lung,andBloodInstitute/American Heart Association conference on scientific issues related todefinition.
/ Circulation. 2004 Jan 27;109(3):433-8.167. Haffner S.M. Prediabetes, insulin resistance, inflammation and CVD risk /S.M. Haffner // Diabetes Res. Clin. Pract. - 2003. - V.61, №1 - P. S9-S18.168. Hansen T. Identification of a common amino acid polymorphism in thep85alpha regulatory subunit of phosphatidylinositol 3-kinase: effects on glucosedisappearance constant, glucose effectiveness, and the insulin sensitivity index / T.Hansen [et al.] // Diabetes. - 1997. - V.46. - P. 494-501.169. Henker F.O.
Psychosomatic illness // Psychosomatics. - 1984. - Vol.25, №1.-P.19-24.133170. Hunt, S. The Nottingham Health profile: subjective status and medicalconsultations / S. Hunt, S. McKenna, J. McEven // Soc. Sci. Med. – 1981. – 15. – P.221.171. Isomaa В., Almgren P., Tuomi Т., Forscn В. Cardiovascular morbidity andmortality associated with the metabolic syndrome (Botnia Study) // Dial) Car.
-2001 №24.-P. 683-689.172. Jia W.P., Xiang K.S., Chen L. et al. Epidemiological study on obesity and itscomorbidities in urban Chinese older than 20 years of age in Shanghai, China. ObesRev., 2002. P. 157-165.173. Jones, P. W. St George's Respiratory Questionnaire : development,interpretation and use Text. / P. W. Jones // Eur. Respir. Rev. 2002. -Vol.12, №83.-P.63-64.174. KaplanN.M. The deadly quartet. Upper-body obesity, glucose intolerance,hypertriglyceridemia, hypertension // Arch.
Intern. Med. - 1989. Vol. 149, № 7. - P.1514-1520175. Katz S. The science of quality of life. J Chron Dis 1987; 40(6); 459-463)176. Kim S.H. The metabolic syndrome: one step forward, two steps back / S.H.Kim, G.M. Reaven. // Diabetes Vase. Dis. Res. - 2004. - V.l, №2. - P. 68¬75.177. MacDonald A.J., Bouchier V.A. Mental disorders in somatic patients // Brit. J.Psych. - 1980.
- Vol. 136. - P. 276-283.178. Mancia G. Metabolic syndrome in the Pressioni Arteriöse Monitorate E LoroAssociazioni (PAMELA) study: daily life bloodpressure, cardiac damage, andprognosis / G. Mancia [et al.] // Hypertension. - 2007. - V. 49. - P. 40-47.179. Marques-Vidal P., Mazoyer E., Bongard V., Gourdy P. Prevalence of insulinresistance syndrome in southwestern France and its relationship with inflammatoryand hemostatic markers // Diab Car. 2002.
- №25. - P. 13711377. Laakso M., 1993180. Mule G. Influence of metabolic syndrome on hypertension-related target organdamage / G. Mule [et al.] // J. Intern. Med. - 2005. - V.257. - P. 503-513.134181. Porzio O. The Gly972 Arg amino acid polymorphism in IRS-1 impairs insulinsecretion in pancreatic beta cells / O.
Porzio [et al.] // J. Clin. Investigat. - 1999.-V.104. - P.357-364.182. Quality of Life Assessment: an Annotated Bibliography. – Geneva, 1994. –223 p.183. Reaven G. Pathophysiology of insulin resistance in human disease // Physiol.Rev. - 1995. - Vol. 75, № 3. - P. 473-486.;184. Reaven G.M.
Diet and Syndrome X // Curr. Atheroscler. Rep. - 2000. -Vol. 2,№6.-P. 503-507.;185. Reaven G.M. Insulin resistance/compensatory hyperinsulinemia, essentialhypertension, and cardiovascular disease // J. Clin. Endocrinol. Metab. - 2003. - Vol.88, № 6. - P. 2399-2403 .186. Reaven G.M.
Role of insulin resistance in human disease : Banting lecture1988 // Diabetes. - 1988. - Vol. 37, № 12. - P. 1595-1607187. Robert H. Eckel, Scott M. Grundy,Paul Z. Zimmet,James I. Cleeman, Karen A.Donato, Jean-Charles Fruchart, W. Philip T. James, Catherine M. Loria, Sidney C.SmithHarmonizing the Metabolic Syndrome Сirculation. 2009 Oct20 ;120(16):1640-5.188. Rosenthal, N. E. Seasonal affective disorder and phototherapy / N.
E.Rosenthal [et al.] // Annals of the New York Academy of Sciences. – 1985. – 453. –p. 260–9. Seed, P. Quality of life / P. Seed, G. Lloyd. – London: Jessica KingsleyPublishers, 1997. – 465 p.189. Schmitz J. Smoking cessation in women with cardiac risk // Am J Med Sei. 2003. - № 326. - P. 192-196.190. Salmon D., Mercuel A. Depressive states during severe infectious illnesses //Encephale..
- 1997. - Vol. 23, №5. - P. 9-13.191. Samonthon K., Samonthon С. Возвращение к здоровью (Новый взгляд натяжелые болезни). СПб., 1997.192. Stern M.B. Strategies and prospects for finding insulin resistance genes / M.B.Stern. // J. Clin. Invest. - 2000. - V. 106. - P.323-327.135193. Takahashi S. Increased visceral fat accomulation further aggravates the risk ofinsulin resistance in gout / S.
Takahashi, Y. Moriwak, Z. Tsutsumi. // Metabolism. 2001. - V. 50, №4. - P.393-398.194. Ventergodt S., 2003 Ventegodt, S. Quality of life as medicine: a pilot study ofpatients with chronic illness and pain Text. / S. Ventegodt, J. Merrick, N. J. Anderson// Scientific World J.-2003. № 3.
-P. 250-532.195. Virkamai A. Protein-protein interaction in insulin signaling and the molecularmechanisms of insulin resistance / A. Virkamai, U. Kohjiro, R.C. Kahn. //J. Clin,Investig. - 1999. - V. 103. - P. 931-943.196. Ware, J. E. Sf-36 Health Survey. Manuel and Interpretation Guide, Lincoln,RI.: Quality Metric Incorporated / J.
E. Ware, K. K. Snow, M. Kosinski, B. Gandek.– 2000. – 150 р.197. Ware, J. E. The MOS 36-item short-form health survey (SF-36). Conceptualframework and item selection / J. E. Ware, C. D. Sherburne // Med. Care. –1992. –Vol. 30. – P. 437–483.198. Yudkin S.J. Inflammation, obesity, stress and coronary heart diseas: isinterleukin-6 the link? / S.J Yudkin, M. Kumari, S.E. Humphries. // Ateroscl. - 2000.- V. 148. - P.209-214.199. Zigmond A.S., Snaith R.P. The HADS: Hospital Anxiety and DepressionScale. Windsor 1994: NFER Nelson.200. Zemel M.B. Insulin resistance, obesity and hypertension: an overview / M.B.Zemel. // J. Nutr.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
